Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
Molecules (Basel, Switzerland), 2021-09, Vol.26 (19), p.5795 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules26195795 ;PMID: 34641339
Full text available